ASHLEY DURCHHALTER: Open Payments
NPI 1649653619 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $248 |
| UCB, Inc. | 1 | $125 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $76 |
| Janssen Biotech, Inc. | 3 | $70 |
| Galderma Laboratories, L.P. | 2 | $45 |
| LNHC, Inc | 2 | $45 |
| Botanix SB Inc | 2 | $39 |
| Journey Medical Corporation | 2 | $30 |
| ABBVIE INC. | 1 | $20 |
| Incyte Corporation | 1 | $18 |
Products named: OTEZLA, Bimzelx, TREMFYA, NEMLUVIO, ZELSUVMI, Winlevi, SOFDRA, RINVOQ.
Industry payments across CT — which companies pay providers there.
